Wenjing Liu
Kunming, 650500, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Corrigendum to "PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer" [Cancer Lett. 598 (2024) 217112].
Journal: Cancer letters
Published: June 30, 2026
DHL-11, a novel prieurianin-type limonoid isolated from Munronia henryi, targeting IMPDH2 to inhibit triple-negative breast cancer.
Journal: Acta pharmaceutica Sinica. B
Published: March 10, 2025
Neutrophil Extracellular Traps (NETs) in health and disease.
Journal: Molecular biomedicine
Published: November 03, 2024
Targeting PRMT5 through PROTAC for the treatment of triple-negative breast cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 21, 2024
An essential role of the E3 ubiquitin ligase RNF126 in ensuring meiosis I completion during spermatogenesis.
Journal: Journal of advanced research
Published: June 13, 2024
Targeting the HECTD3-p62 axis increases the radiosensitivity of triple negative breast cancer cells.
Targeting the HECTD3-p62 axis increases the radiosensitivity of triple negative breast cancer cells.
Journal: Cell death discovery
Published: April 16, 2024
PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer.
Journal: Cancer letters
Published: March 13, 2024
E3 ubiquitin ligase BCA2 promotes breast cancer stemness by up-regulation of SOX9 by LPS.
Journal: International journal of biological sciences
Published: November 17, 2023
Last Updated: 09/26/2026